Second-line dovitinib in metastatic endometrial cancer.

Block, Matthew S

Second-line dovitinib in metastatic endometrial cancer. [electronic resource] - The Lancet. Oncology Jun 2015 - 604-6 p. digital

Publication Type: Journal Article; Comment

1474-5488

10.1016/S1470-2045(15)70190-7 doi


Antineoplastic Combined Chemotherapy Protocols
Benzimidazoles--administration & dosage
Endometrial Neoplasms--drug therapy
Female
Humans
Quinolones--administration & dosage
Receptor, Fibroblast Growth Factor, Type 2--genetics